Joachim Diebold

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

Dmitri Lodygin, Valery Tarasov, Alexey Epanchintsev et al. · Cell Cycle · 2008 · 784 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

Julien Mazières, Solange Peters, Benoît Lepage et al. · Journal of Clinical Oncology · 2013 · 659 citations

Medicine, Molecular Genetics, Oncology +15

From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

Oleg Schmidt‐Kittler, Thomas Ragg, Angela Daskalakis et al. · Proceedings of the National Academy of Sciences · 2003 · 624 citations · Full text

Medicine, Genetics, Oncology +17

Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> Registry

Oliver Gautschi, Julie Milia, Thomas Filleron et al. · Journal of Clinical Oncology · 2017 · 356 citations · Full text

Medicine, Molecular Genetics, Oncology +17